Trial · NCT01160640
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Placebo | 55 | 117 | 59 |
| other | Nausea | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Metronidazole | 58 | 116 | 58 |
| other | Vomiting | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Placebo | 37 | 117 | 39 |
| other | Vomiting | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Metronidazole | 40 | 116 | 42 |
| other | Diarrhea | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Placebo | 30 | 117 | 30 |
| other | Diarrhea | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Metronidazole | 39 | 116 | 40 |
| other | Vaginal discharge, abnormal | Reproductive system and breast disorders | Ceftriaxone, Doxycycline, Placebo | 4 | 117 | 4 |
| other | Vaginal discharge, abnormal | Reproductive system and breast disorders | Ceftriaxone, Doxycycline, Metronidazole | 9 | 116 | 9 |
| other | Altered taste | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Placebo | 5 | 117 | 5 |
| other | Altered taste | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Metronidazole | 8 | 116 | 8 |
| other | Bacterial vaginosis | Infections and infestations | Ceftriaxone, Doxycycline, Placebo | 8 | 117 | 8 |
| other | Bacterial vaginosis | Infections and infestations | Ceftriaxone, Doxycycline, Metronidazole | 4 | 116 | 4 |
| other | Headache | General disorders | Ceftriaxone, Doxycycline, Placebo | 10 | 117 | 10 |
| other | Headache | General disorders | Ceftriaxone, Doxycycline, Metronidazole | 12 | 116 | 12 |
| other | Loose stool | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Placebo | 9 | 117 | 9 |
| other | Loose stool | Gastrointestinal disorders | Ceftriaxone, Doxycycline, Metronidazole | 6 | 116 | 6 |
| other | Vaginal itching | Reproductive system and breast disorders | Ceftriaxone, Doxycycline, Placebo | 7 | 117 | 7 |
| other | Vaginal itching | Reproductive system and breast disorders | Ceftriaxone, Doxycycline, Metronidazole | 11 | 116 | 11 |
| other | Vulvovaginal candidiasis | Infections and infestations | Ceftriaxone, Doxycycline, Placebo | 7 | 117 | 8 |
| other | Vulvovaginal candidiasis | Infections and infestations | Ceftriaxone, Doxycycline, Metronidazole | 18 | 116 | 18 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01160640/events